FIELD: biotechnology.
SUBSTANCE: RNA-interference polynucleotide is administered in conjunction with a targeting melittin peptide modified by asialoglycoprotein (ASGPr) receptors, for delivery to a mammal liver cell.
EFFECT: functional penetration through liver cells membranes to provide RNA-interference polynucleotide movement into the cells.
20 cl, 5 dwg, 11 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
CONJUGATES FOR DELIVERY OF POLYNUCLEOTIDES IN VIVO, CONTAINING BONDS SENSITIVE TO ENZYMATIC DEGRADATION | 2011 |
|
RU2619453C2 |
POLYCONJUGATES FOR POLYNUCLEOTIDE INTRODUCTION IN VIVO | 2007 |
|
RU2430740C2 |
LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | 2011 |
|
RU2629957C2 |
LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2011 |
|
RU2582235C2 |
NEW OLIGONUCLEOTIDES CONJUGATES AND USE THEREOF | 2012 |
|
RU2599449C1 |
LIPID NANOPARTICLES FOR IN VIVO MEDICINAL PRODUCTS DELIVERY AND THEIR USE | 2020 |
|
RU2799045C1 |
DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 |
|
RU2642640C2 |
IMPROVED NANOPARTICLE TYPE OLIGONUCLEOTIDE STRUCTURE HAVING HIGH EFFICIENCY AND METHOD FOR PREPARING SAME | 2014 |
|
RU2670164C2 |
DOUBLE-STRANDED RNA MOLECULE FOR MIR-34A ACTIVITY IN CELL | 2012 |
|
RU2615117C2 |
NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN CELL | 2018 |
|
RU2822093C1 |
Authors
Dates
2017-06-22—Published
2011-12-16—Filed